Accessibility StatementSkip Navigation NEW YORK, Sept. 11, 2025 /PRNewswire/ -- As previously announced, MongoDB, Inc. (NASDAQ: MDB) will host an investor session at MongoDB.local in New York City. The day will begin at 9:00 a.m. ET on Wednesday, September 17 with a MongoDB.local keynote presentation from Dev Ittycheria, MongoDB's President & CEO. The investor session, hosted by MongoDB's executive team, will follow from 11:00 a.m. – 3:00 p.m. ET. Both the keynote presentation and the investor session will ...

Core Insights - Profusa, Inc. has announced significant leadership changes, including the appointment of Peter O'Rourke as lead independent director and Fred Knechtel as Chief Financial Officer, following its business combination with NorthView Acquisition Corp [1][2] - The company is positioned at a critical juncture as it prepares to launch its innovative biosensor platform into global markets, with leadership bringing extensive experience in healthcare and finance [2][3] Leadership Appointments - Peter O'Rourke, former Acting U.S. Secretary of Veterans Affairs, brings a wealth of experience overseeing a large healthcare system serving over 9 million veterans across 1,300 facilities [2][3] - Fred Knechtel has a strong background in finance and operations, having worked with various companies in sectors such as life sciences and automotive, and has been a trusted partner to Profusa [2][3][4] Company Vision and Technology - Profusa aims to revolutionize health monitoring through its biosensor technology, which is designed to provide continuous, actionable medical-grade data [4] - The company focuses on developing long-lasting, injectable biosensors that offer personalized biochemical signatures for both personal and medical use [4]

Core Insights - Profusa, Inc. has made an initial investment of $1 million in Bitcoin as part of its treasury strategy to hedge against macroeconomic uncertainties [1] - The company has partnered with BlockFills to implement its Bitcoin treasury management strategy [1] - Profusa's CEO emphasized the importance of this investment in maximizing their Bitcoin holdings while maintaining capital for their AI-driven digital health platform [2] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemistry [3] - The company aims to provide personalized biochemical data through its long-lasting, injectable biosensors and intelligent data platform [3] - Profusa is led by a team of experienced management and a world-class board of directors [3]